Reneo Pharmaceuticals Inc.

Reneo Pharmaceuticals Inc. is focused on clinical research involving impaired hepatic function, with attention to how investigational therapies are handled in people with normal liver function and varying degrees of hepatic impairment.

• Normal hepatic function
• Mild hepatic impairment
• Moderate hepatic impairment
• Severe hepatic impairment

The sponsor’s research interest centers on pharmacokinetics in liver-compromised populations, supporting evaluation of treatment behavior across clinically relevant levels of liver dysfunction.